$31.27-1.67 (-5.06%)
News25/Ratings6
Price$31.27-1.32 (-4.05%)
01:45 PM07:45 PM
News · 26 weeks52-64%
2025-10-262026-04-19
Mix3290d
- Insider17(53%)
- Other6(19%)
- SEC Filings4(13%)
- Earnings3(9%)
- Analyst1(3%)
- Leadership1(3%)
Latest news
25 items- PRHeartflow to Report First Quarter 2026 Financial Results on May 14, 2026SAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the first quarter of 2026 after market close on Thursday, May 14, 2026. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on May 14, 2026. Those interested in listening to the conference call should register online using this link. Once registered, participants will receive dial-in numbers and a unique PIN to join the call. Participants are encouraged to register more than 15 minutes prior to the start of the call. A live an
- INSIDERSEC Form 4 filed by Farquhar John C.M.4 - Heartflow, Inc. (0001464521) (Issuer)
- PRHeartflow Files Patent Infringement Lawsuit Against CleerlyMOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed a patent infringement lawsuit against Cleerly, Inc. in the United States District Court for the Eastern District of Texas. The complaint seeks permanent injunctive relief and damages arising from Cleerly's unauthorized and continued use of Heartflow's patented technology. Heartflow asserts that Cleerly's Ischemia, Plaque Analysis, and Compare products infringe six of Heartflow's patents with priority dates from 2012 to 2018, protecting Heartflow innovations developed years before the introductio
- INSIDERSEC Form 4 filed by Rogers Campbell4 - Heartflow, Inc. (0001464521) (Issuer)
- SECSEC Form SCHEDULE 13G filed by Heartflow Inc.SCHEDULE 13G - Heartflow, Inc. (0001464521) (Subject)
- PRHow Decentralized AI is Unlocking Value in Cardiac DiagnosticsISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.VANCOUVER,BC, March 27, 2026 /CNW/ -- USANewsGroup.com News Commentary – Heart disease is a quiet crisis that is draining healthcare resources worldwide, currently costing the European Union over €282 billion annually while tragically claiming 1.7 million lives a year[1]. This immense structural pressure is acting as a catalyst for smart money, with institutional capital rapidly accumulating positions in scalable, AI-enabled diagnostic platforms. In fact, peer-reviewed data now confirms that AI-driven healthcare startups command the largest share of venture funding in the entire biopharmaceutical sector[2]. At the center of this pivotal transit
- INSIDERSEC Form 4 filed by Lightcap Jeffrey C4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERSEC Form 4 filed by Healthcor Partners Management Lp4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERSEC Form 4 filed by Rogers Campbell4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERSEC Form 4 filed by Farquhar John C.M.4 - Heartflow, Inc. (0001464521) (Issuer)
- SECSEC Form S-8 filed by Heartflow Inc.S-8 - Heartflow, Inc. (0001464521) (Filer)
- SECSEC Form 10-K filed by Heartflow Inc.10-K - Heartflow, Inc. (0001464521) (Filer)
- SECHeartflow Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Heartflow, Inc. (0001464521) (Filer)
- PRHeartflow Reports Fourth Quarter and Full Year 2025 Financial ResultsMOUNTAIN VIEW, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Highlights Total revenue of $49.1 million, a 40% increase year-over-yearGross margin of 79.5%, non-GAAP gross margin of 79.9%Net operating loss of $17.8 million, non-GAAP net operating loss of $12.5 millionU.S. installed base of 1,465 accounts as of December 31, 2025U.S. Plaque installed base of 489 accounts as of December 31, 2025Aetna began coverage of Heartflow Plaque Analysis, bringing total U.S. covered lives
- INSIDERDirector Barabe Timothy C exercised 8,667 shares at a strike of $2.22, increasing direct ownership by 5% to 179,521 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Executive Officer Farquhar John C.M. was granted 2,631 shares and sold $290,886 worth of shares (12,837 units at $22.66), decreasing direct ownership by 2% to 581,450 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERDirector Cullivan Julie A sold $228,050 worth of shares (9,122 units at $25.00), decreasing direct ownership by 25% to 27,291 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Heartflow Inc.SCHEDULE 13G/A - Heartflow, Inc. (0001464521) (Subject)
- SECSEC Form 144 filed by Heartflow Inc.144 - Heartflow, Inc. (0001464521) (Subject)
- INSIDERDirector Barabe Timothy C exercised 2,497 shares at a strike of $8.33, increasing direct ownership by 1% to 170,854 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- PRHeartflow to Participate in the Morgan Stanley Technology, Media & Telecom ConferenceMOUNTAIN VIEW, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Morgan Stanley Technology, Media & Telecom Conference. The presentation will take place in San Francisco, CA, on Tuesday, March 3, 2026, at 10:45 a.m. PT / 1:45 p.m. ET. A live and archived version of the fireside chat will be available on the Investor Relations section of the Heartflow website at https://ir.heartflow.com. About Heartflow's Technology and ResearchHeartflow's technology is redefining precision cardiovascular care throu
- INSIDERChief Medical Officer Rogers Campbell sold $1,595,486 worth of shares (65,153 units at $24.49) and exercised 67,016 shares at a strike of $5.84, increasing direct ownership by 3% to 76,034 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- PRHeartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026MOUNTAIN VIEW, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Wednesday, March 18, 2026. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on March 18, 2026. Those interested in listening to the conference call should register online using this link. Once registered, participants will receive dial-in numbers and a unique PIN to join the call. Participants are encouraged to register more than 15 minutes prior to the s
- PRHeartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely Measuring Heart Disease Risk in Former Professional AthletesMOUNTAIN VIEW, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced a significant expansion of its groundbreaking GAMEFILM Registry. Building on a successful initial phase enrolling retired National Football League (NFL) athletes, the study will now extend to include former players from the National Basketball Association (NBA) and the National Hockey League (NHL), broadening Heartflow's initiative to protect the heart health of professional athletes across major sports. Retired NBA star Muggsy Bogues was one of the first former professional basketball players to join the GAMEFILM
- INSIDERChief Accounting Officer, VP Jones Marie L. was granted 21,629 units of Common Stock. and covered exercise/tax liability with 94 units of Common Stock., increasing direct ownership by 213% to 31,650 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)